Two Sigma Investments’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $56.6M | Buy |
225,631
+85,692
| +61% | +$21.3M | 0.05% | 448 |
|
|
2025
Q4 | $38.5M | Buy |
139,939
+38,738
| +38% | +$10.6M | 0.05% | 430 |
|
|
2025
Q3 | $26.5M | Sell |
101,201
-482,864
| -83% | -$117M | 0.04% | 526 |
|
|
2025
Q2 | $128M | Buy |
584,065
+61,238
| +12% | +$13.1M | 0.23% | 109 |
|
|
2025
Q1 | $117M | Buy |
522,827
+446,839
| +588% | +$123M | 0.25% | 92 |
|
|
2024
Q4 | $24.9M | Sell |
75,988
-68,732
| -47% | -$21.6M | 0.05% | 417 |
|
|
2024
Q3 | $43.4M | Buy |
144,720
+62,337
| +76% | +$19.1M | 0.1% | 264 |
|
|
2024
Q2 | $27.1M | Buy |
82,383
+81,557
| +9,874% | +$28.8M | 0.06% | 359 |
|
|
2024
Q1 | $327K | Sell |
826
-26,647
| -97% | -$9.86M | ﹤0.01% | 2524 |
|
|
2023
Q4 | $9.67M | Buy |
27,473
+20,873
| +316% | +$7.39M | 0.02% | 693 |
|
|
2023
Q3 | $2.48M | Sell |
6,600
-49,294
| -88% | -$19.1M | 0.01% | 1253 |
|
|
2023
Q2 | $21.4M | Buy |
55,894
+49,294
| +747% | +$17.6M | 0.05% | 393 |
|
|
2023
Q1 | $2.29M | Sell |
6,600
-324,313
| -98% | -$94.8M | 0.01% | 1302 |
|
|
2022
Q4 | $77.9M | Buy |
+330,913
| New | +$78.4M | 0.24% | 100 |
|
|
2022
Q3 | – | Sell |
-4,757
| Closed | -$1.44M | – | 2867 |
|
|
2022
Q2 | $1.44M | Buy |
+4,757
| New | +$1.55M | ﹤0.01% | 1368 |
|
|
2021
Q2 | – | Sell |
-18,888
| Closed | -$5.32M | – | 4629 |
|
|
2021
Q1 | $5.32M | Buy |
+18,888
| New | +$5.41M | 0.01% | 1004 |
|
|
2018
Q2 | – | Sell |
-36,297
| Closed | -$3.21M | – | 3705 |
|
|
2018
Q1 | $3.21M | Buy |
36,297
+3,111
| +9% | +$291K | 0.01% | 1197 |
|
|
2017
Q4 | $3.27M | Sell |
33,186
-12,610
| -28% | -$1.24M | 0.01% | 1144 |
|
|
2017
Q3 | $4.41M | Sell |
45,796
-108,078
| -70% | -$9.78M | 0.02% | 871 |
|
|
2017
Q2 | $14.5M | Buy |
153,874
+135,491
| +737% | +$12.5M | 0.05% | 409 |
|
|
2017
Q1 | $1.5M | Buy |
+18,383
| New | +$1.54M | 0.01% | 1637 |
|
|
2016
Q4 | – | Sell |
-6,920
| Closed | -$516K | – | 3564 |
|
|
2016
Q3 | $516K | Buy |
+6,920
| New | +$549K | ﹤0.01% | 2419 |
|
|
2016
Q2 | – | Sell |
-7,199
| Closed | -$499K | – | 3286 |
|
|
2016
Q1 | $499K | Buy |
+7,199
| New | +$433K | ﹤0.01% | 2064 |
|
|
2014
Q3 | – | Sell |
-25,416
| Closed | -$1.07M | – | 2093 |
|
|
2014
Q2 | $1.07M | Sell |
25,416
-17,634
| -41% | -$755K | ﹤0.01% | 1283 |
|
|
2014
Q1 | $1.9M | Buy |
+43,050
| New | +$2.03M | 0.01% | 954 |
|
|
2013
Q4 | – | Sell |
-66,885
| Closed | -$2.75M | – | 2409 |
|
|
2013
Q3 | $2.75M | Sell |
66,885
-753
| -1% | -$28.7K | 0.02% | 686 |
|
|
2013
Q2 | $2.38M | Buy |
+67,638
| New | +$2.23M | 0.02% | 796 |
|
Other funds holding WST
VCM
VPM
GIM
Two Sigma Investments's WST Position: Q1 2026 in Review
Two Sigma Investments increased its West Pharmaceutical (WST) stake by 61% in Q1 2026, buying an estimated $21.3M and bringing the position to 225,631 shares worth $56.6M. The position accounts for 0.05% of the portfolio, ranked #448.
Two Sigma Investments first reported a position in WST in Q2 2013 and has held it in 27 quarters since. The position peaked at $128M in Q2 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Two Sigma Investments held 225,631 shares of West Pharmaceutical worth $56.6M as of Q1 2026.
- Two Sigma Investments bought 85,692 West Pharmaceutical shares in Q1 2026, an estimated $21.3M.
- West Pharmaceutical made up 0.05% of Two Sigma Investments's portfolio in Q1 2026, its #448 holding.
- Two Sigma Investments first reported a position in West Pharmaceutical in Q2 2013 and has held it in 27 quarters since.
- Two Sigma Investments's West Pharmaceutical position peaked at $128M in Q2 2025.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.